Regeneron Pharmaceuticals
REGN
REGN
1,058 hedge funds and large institutions have $54.7B invested in Regeneron Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 93 funds opening new positions, 374 increasing their positions, 413 reducing their positions, and 110 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,058
Holders Change
-31
Holders Change %
-2.85%
% of All Funds
17.89%
Holding in Top 10
22
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.37%
New
93
Increased
374
Reduced
413
Closed
110
Calls
$707M
Puts
$974M
Net Calls
-$267M
Net Calls Change
+$159M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$481M |
| 2 |
JPMorgan Chase & Co
New York
|
+$422M |
| 3 |
Renaissance Technologies
New York
|
+$179M |
| 4 |
Morgan Stanley
New York
|
+$177M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$168M |
Top Sellers
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$463M |
| 2 |
Harris Associates
Chicago,
Illinois
|
-$302M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$300M |
| 4 |
Two Sigma Investments
New York
|
-$145M |
| 5 |
Two Sigma Advisers
New York
|
-$124M |
